Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure

NCT04915287 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

476

Enrollment

OTHER

Sponsor class

Conditions

Thrombocytopenia; Drugs
Chronic Liver Disease

Interventions

DRUG: Avatrombopag maleate
BIOLOGICAL: Platelet transfusion
DRUG: Medicine

Sponsor

Chinese PLA General Hospital